MiraeAsset Financial Group
Signal active
Investment Firm
Overview
N/A
Highlights
Founded
1997
Industry
Employees
0
Investment
6
Lead Investment
2
Exits
3
Stages
Early Stage Venture, Late Stage Venture
Investor Type
Private Equity Firm
Location
Asia
Contact Information
Social
Profile Resume
MiraeAsset Financial Group, established in 1997 and headquartered in Asia., specializes in Early Stage Venture, Late Stage Venture investments across Information Technology, Software, Biotechnology, Medical, Health Care, Medical Device, Finance, Business Development, Application Performance Management, Financial Services. The organization boasts a portfolio of 6 investments, with an average round size of $162.3M and 3 successful exits. Their recent investments include Septerna, Third Rock Ventures, Invus, RA Capital Management, Deep Track Capital. The highest investment round they participated in was $112.2B. Among their most notable exits are Septerna and Third Rock Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
MiraeAsset Financial Group has made 6 investments. Their most recent investment was on Jul 11, 2023, when Septerna raised $150.0M.
MiraeAsset Financial Group has made 1 diversity investments. Their most recent diversity investment was on Jun 16, 2020, when 4D Molecular Therapeutics raised $75.0M.
investments
6
Diversity investments
1
Lead investments
2
Number of exits
3
Investments
6
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 22, 2021 | EpimAb Biotherapeutics | Biotechnology | 120.0M |
| Oct 15, 2021 | MindwareWorks | Software | 3.5M |
| Nov 29, 2021 | Abogen Biosciences | Biotechnology | 300.0M |
| Jul 11, 2023 | Septerna | Information Technology | 150.0M |
MindwareWorksExits
3
Funding Timeline
Funding rounds
6
Investors
0
Funds
0
Funding Rounds
6
MiraeAsset Financial Group has raised 6 rounds. Their latest funding was raised on Jul 11, 2023 from a Series B - Septerna round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 22, 2021 | Series C - EpimAb Biotherapeutics | - | 120.0M | - |
| Oct 15, 2021 | Series A - MindwareWorks | - | 3.5M | - |
| Nov 29, 2021 | Series C - Abogen Biosciences | - | 300.0M | - |
| Jul 11, 2023 | Series B - Septerna | - | 150.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.